title: [The effect of thalidomine-induced NF-kappa B activation on malignant transformation of hepatocytes].
authors.affiliation: Research Center of Clinical Medicine, Affiliated Hospital, Nantong University, Nantong 226001, China. yaodf@ahnmc.com
authors.forename: Deng-fu
authors.initials: DF
authors.lastname: Yao
authors.forename: Hong-bo
authors.initials: HB
authors.lastname: Yu
authors.forename: Jun-jun
authors.initials: JJ
authors.lastname: Shen
authors.forename: Yi-lang
authors.initials: YL
authors.lastname: Wang
authors.forename: Xin-hua
authors.initials: XH
authors.lastname: Wu
authors.forename: Li-wei
authors.initials: LW
authors.lastname: Qiu
authors.forename: Wei
authors.initials: W
authors.lastname: Wu
mesh_terms: D015073:2-Acetylaminofluorene; D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology*; D007150:Immunohistochemistry; D008099:Liver / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology*; D008297:Male; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D013792:Thalidomide / Q000494:pharmacology*
chemical_list: D020533:Angiogenesis Inhibitors; D016328:NF-kappa B; D013792:Thalidomide; D015073:2-Acetylaminofluorene